The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 67 | 36.3x | 20.1x | Above average | |
Growth | 33 | 4.8% | 5.6% | Below average | |
Quality | 50 | 2.2% | 7.6% | Near average | |
Safety | 85 | -2.4x | 0.4x | Above average | |
Capital Return | 55 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
USANA Health Sciences, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy USANA Health Sciences, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
USANA Health Sciences stock shows a state of complete stability in analyst forecasts across timeframes (D1, W1, M1), with the price target holding steady at 35 dollars. This consistency reflects the absence of any recent revisions by research firms, noting that only one analyst currently covers the stock, which leads to zero dispersion in estimates but simultaneously raises concentration risks and a lack of informational liquidity.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.